[Pharmacoeconomics of asthma].
Pharmacoeconomics is important in asthma as this condition continues to increase in prevalence throughout the world, consuming a larger and larger share of total health care budgets. Understanding how pharmacoeconomics can be applied in evaluating the cost-effectiveness of asthma treatments can be important in determining proper asthma care in a climate of limited resources in Poland.
Jahnz-Rózyk
Karina
K
Wojskowy Instytut Medyczny, Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii CSK MON w Warszawie. krozyk@poczta.onet.pl
Targowski
Tomasz
T
D018927:Anti-Asthmatic Agents / Q000191:economics* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000191:economics*; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D006801:Humans; D011044:Poland
D018927:Anti-Asthmatic Agents